Skip to content

Clinical suite domain map

The suite is organized around recognizable clinical product responsibilities. Each vertical page separates observed industry behaviour from the proposed TechSol domain decision.

Vertical Owns Review pack
Platform identities, content versions, lifecycle enforcement, workflow, authority, audit, signatures and integration identity Platform model
CTMS Study/Country/Site operations, milestones, operational metrics, issues and monitoring CTMS model
eTMF expected records, classification, quality, completeness, timeliness and inspection availability eTMF model
Study Startup feasibility, selection, requirements, approvals, milestones, greenlight and activation readiness Startup model
Payments fee schedules, earned payable items, requests, adjustments and payment reconciliation Payments model
Site Collaboration sponsor/CRO-to-site document exchange, requests, reconciliation and distributions Site Collaboration model
Study Training curricula, training matrices, assignments, completion, qualification and evidence Training model
Disclosures registry obligations, registration/results versions, validation, approval and submission Disclosures model
Site & Investigator Intelligence curated investigator, institution, location and affiliation reference identity Intelligence model
EDC study collection design, Subjects, Casebooks, Events, Forms, Items, rules, queries, review, signatures and lock EDC model
Clinical Data Quality multisource ingestion, alignment, review, checks, reconciliation, provider queries and downstream packages Data Quality model
RTSM screening/randomization transaction, concealment, kit assignment, inventory, resupply and accountability RTSM model
eCOA instrument versions, schedules, administrations, responses, adherence and data changes eCOA model
Platform identities and controls
├─ Site & Investigator Intelligence ──> CTMS / Startup master references
│ ├─ Startup ──> site selected / greenlit / activated
│ ├─ Payments <── visits, procedures and site fee events
│ ├─ Site Collaboration <──> research site
│ ├─ Study Training ──> qualification evidence ──> eTMF
│ └─ Disclosures <── study/country milestones
├─ CTMS ── Study / Country / Site ──> EDC, RTSM, eCOA
├─ RTSM ── screening / randomization / kits ──> EDC, Clinical Data Quality
├─ EDC ── Subjects / Visits / Procedures / Deviations ──> CTMS, Data Quality, Payments
├─ eCOA ── assessment data / adherence ──> Clinical Data Quality
├─ Clinical Data Quality ── harmonized reviewed data packages ──> downstream analysis
└─ eTMF <── final evidence from operations, data, training, safety and closeout

Arrows carry named, versioned facts. They do not grant the receiving product authority to edit the publisher’s object.

The model no longer presents EDC as generic forms and data points or eTMF as generic evidence.

  • EDC now preserves the recognizable hierarchy of Study, Site, Subject, Casebook, Event Group, Event, Form, Item Group and Item, including rule-driven schedule changes, amendments, SDV/DMR, signature invalidation, freeze and lock.
  • eTMF now maps EDL, EDL Item/Expected Document, matching, steady-state content, quality issues and TMF health into explicit expectation, fulfillment and assessment objects.
  • CTMS distinguishes authoritative operations from integrated Subject/Visit projections and models Monitoring Event snapshots explicitly.
  • Every vertical provides its source list and states where the TechSol model differs or still needs a product decision.

EDC is the reference-depth candidate. The remaining verticals are evidence-backed v0.1 reconstructions: their boundaries and main objects are now recognizable, but their field-level contracts, full refusal catalogs and scenario suites still require product-manager review.

The evidence method states how product behaviour is promoted into the domain model and prevents vendor configuration from becoming architecture by accident.